Time-in-range as a target in type 2 diabetes: An urgent need
| العنوان: | Time-in-range as a target in type 2 diabetes: An urgent need |
|---|---|
| المؤلفون: | Jothydev Kesavadev, Arun Shankar, Banshi Saboo, Vidisha Patel, Gopika Krishnan, Shruti V. Sheth, Meera B. Krishna |
| المصدر: | Heliyon Heliyon, Vol 7, Iss 1, Pp e05967-(2021) |
| بيانات النشر: | Elsevier BV, 2021. |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | 0301 basic medicine, medicine.medical_specialty, HbA1c, Population, Review Article, Type 2 diabetes, Time-in-range, 03 medical and health sciences, 0302 clinical medicine, Diabetes mellitus, Medicine, lcsh:Social sciences (General), lcsh:Science (General), Intensive care medicine, education, Continuous glucose monitoring, Glycemic, education.field_of_study, Multidisciplinary, business.industry, Type 2 Diabetes Mellitus, medicine.disease, Clinical trial, 030104 developmental biology, lcsh:H1-99, Metric (unit), business, 030217 neurology & neurosurgery, lcsh:Q1-390 |
| الوصف: | Time-in-range emerged as a valuable blood glucose metric, ‘beyond HbA1c’ for a deeper insight into glycemic control in people with diabetes. It denotes the proportion of time that a person's glucose level remains within the desired target range (usually 70–180 mg/dL or 3.9–10.0 mmol/L). Though clinical targets in the current recommendations for type 1 and type 2 diabetes are close enough, their clinical profiles and prevalences are quite different. Type 2 diabetes is the commonest form of diabetes. Many clinical trials have challenged the usefulness of HbA1c as a glycemic target for Type 2 diabetes mellitus. On account of the higher prevalence and complications of type 2 diabetes, more outcomes-based studies are needed to associate time-in-range with its ongoing risk. These studies strongly support the dependability of time-in-range to identify patients with elevated risk in type 2 diabetes. We discuss the utility of time-in-range, a new metric of continuous glucose monitoring as an outcome measure to correlate with type 2 diabetes risks and complications and to analyze the effectiveness of type 2 diabetes management. This approach may support the use of time-in-range as a metric for long-term health outcomes in the type 2 diabetes population. Time-in-range; Type 2 diabetes; Continuous glucose monitoring; HbA1c. |
| تدمد: | 2405-8440 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0956215666264ed886007e401fe3cf1dTest https://doi.org/10.1016/j.heliyon.2021.e05967Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....0956215666264ed886007e401fe3cf1d |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 24058440 |
|---|